• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

CommonSpirit Health Deploys COVID-19 Virtual Triage and Remote Monitoring Across Ambulatory Clinics

Share:

April 7, 2020

CommonSpirit Health is a single healthcare organization formed by Catholic Health Initiatives (CHI), Dignity Health, and Dignity Community Care announces the deployment of Notable Health’s COVID-19 Virtual Triage and Remote Monitoring solution to support clinical staff in their efforts to pre-screen ambulatory patients, limit the spread of novel coronavirus and provide remote care for at-risk individuals. The COVID-19 virtual triage and remote monitoring solution is now in use at ambulatory clinics in Arizona, California and Nevada, with plans to scale broadly across the CommonSpirit Health system in the coming weeks.

Virtual Assessment, Triage, and Remote Monitoring for COVID-19

By integrating seamlessly into existing technology and infrastructure, the COVID-19 solution supports clinician efforts to mitigate disease spread by prompting patients to complete a tailored screening (following CDC criteria) on their mobile device before any scheduled visit, while also providing information on relevant preventative measures and surfacing real-time updates on virus spread and containment efforts. In addition, the technology supports remote monitoring of at-risk patients, giving clinicians the data points to evaluate a patient’s clinical trajectory and make necessary interventions.

Flattening the Curve via Digital Triage and Remote Monitoring

Notable is now offering a free rollout of the COVID-19 solution to existing and future provider and payer partners, which was prompted after a recent use case within the CommonSpirit Health system. Appropriate identification, triage and containment was triggered after a patient reported flu-like symptoms and recent travel to known COVID-19 “hot spots” as part of Notable’s mobile check-in, which prompts patients to enter symptoms and medical history up to 48 hours prior to a scheduled appointment. This information had not been previously captured when the patient called to schedule the appointment. In this case, the patient was redirected to a designated, quarantined location, in accordance with emergency response protocols that protect other patients and clinical staff.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Using patient-provided data captured during the intelligent mobile intake process, the COVID-19 solution can gather clinical history and identify high-risk patients based on a customizable algorithm, automating the instant creation of a natural language HPI (history of present illness) directly within the EMR and flagging pertinent cases for clinic managers and primary responders. This allows clinicians to perform regular remote patient monitoring and deliver custom alerts to identified high-risk patients, as well as use existing integration to place relevant data into structured EMR fields.

“Intelligent automation has unlocked new opportunities for quality care delivery in concrete and profound ways,” said Marijka Grey, MD, executive leader for transformation implementation at CommonSpirit Health. “Any virtual tools that guide our patients to the right level of care during the COVID-19 pandemic can reduce the spread of this disease and keep our patients and caregivers safe from unnecessary exposure.”

Source: HIT Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • J&J Snaps Up Momenta Pharmaceuticals in $6.5 Billion All-Cash DealJ&J Snaps Up Momenta Pharmaceuticals in $6.5 Billion All-Cash Deal
  • HealthLynked Acquires Cura Health & ACO Health PartnersHealthLynked Acquires Cura Health & ACO Health Partners
  • COVID-19 Home-Testing Kit Could Soon be Available for Purchase in UKCOVID-19 Home-Testing Kit Could Soon be Available for Purchase in UK
  • NHS Trusts can Now Recommend Mental Health App Flow to PatientsNHS Trusts can Now Recommend Mental Health App Flow to Patients
  • Fitness Platform Moxie Raises $6.3M in Seed FundingFitness Platform Moxie Raises $6.3M in Seed Funding
  • Boston Scientific Closes Acquisition of Baylis Medical Company Inc.Boston Scientific Closes Acquisition of Baylis Medical Company Inc.
  • Navitas Life Sciences buys up KAI Research, adding to later-stage trial offeringsNavitas Life Sciences buys up KAI Research, adding to later-stage trial offerings
  • Delic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Announces Closing of Non-Brokered Private PlacementDelic’s Acquisition Target, Complex Biotech Discovery Ventures Ltd., Announces Closing of Non-Brokered Private Placement

Trending This Week

  • Pharmaceutical Compliance Software Market 2022 to Showing Impressive Growth By | [no. of Pages: 118] Industry Trends, Share, Size, Top Key Players Analysis and Forecast Research, Shares and Strategies | By Proficient Market Insights
  • Biosimilars Market: Rise in Number of Cancer Patients to Boost Market
  • Biotechnology and Pharmaceutical Services Outsourcing Market Size 2022 Analysis Report By Competitive Vendors in Top Regions and Countries, Production Types, Applications, Growth, Current Trends and Forecast to 2026
  • The Global Wearable Injectors Market Size is Expected to Reach $12.9 Billion By 2028, Rising at a Market Growth of 9.2% CAGR During the Forecast Period
  • Treprostinil Drugs Market – Insights on how Players Have Cemented Their Positions with Disruptive Technologies, Key Players are United Therapeutics, Novartis, and Teva Pharmaceutical Industries Ltd
  • Protect Pharmaceutical Corporation has Acquired Top Notch Software Development Company

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications